跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55,613 条关于
“fulminant C. difficile infection”
全部
55,613
临床试验
45,294
药物
2,294
机构
3,041
资讯
4,984
6个月前
Fecal Microbiota Transplantation Shows Promise for Severe C. difficile Infections Despite Regulatory Challenges
11个月前
Acurx Receives EMA Approval for Pediatric Investigation Plan for Ibezapolstat in C. difficile Infection
去年
Advances in Clostridioides difficile Research: Rebyota's Continued Efficacy and Vancomycin's Impact
去年
VE303 Shows Promise in Preventing Recurrent Clostridioides difficile Infection
去年
Fecal Microbiota Therapy Shows 95% Success Rate in Preventing Recurrent C. difficile Infection
3个月前
RNA-Based Molecular Test More Accurately Distinguishes Active C. difficile Infection from Colonization
去年
Acurx Pharmaceuticals Advances Ibezapolstat for C. difficile Infection
去年
Genetic Analysis Launches GA-map MHI GutHealth Diagnostic Kit for Recurrent C. difficile Infection
去年
Acurx Pharma's Ibezapolstat Receives EMA Guidance for Phase 3 C. difficile Infection Program
去年
Phase 3b Trial Shows Colonoscopic Administration of Rebyota Effective for Preventing Recurrent C. difficile Infection
第 1 页，共 499 页
上一页
下一页
